OncoPep

Onco Pep

Biotechnology, 520 Boston St, Boston, Massachusetts, 01845, United States, 11-50 Employees

oncopep.com

  • LinkedIn

phone no Phone Number: +19*********

Who is ONCOPEP

Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPeps T cell focused techno...

Read More

map
  • 520 Boston St, Boston, Massachusetts, 01845, United States Headquarters: 520 Boston St, Boston, Massachusetts, 01845, United States
  • 2010 Date Founded: 2010
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 6771 | NAICS Code: 523910 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ONCOPEP

OncoPep Org Chart and Mapping

Employees

Emilie Duvallet

Senior Scientist Immunology and Oncology

Amanda Joyce

Scientist (Immuno-Oncology)

Jaehan Park

Chief Strategy Officer (Cso)

Yu-Ting Chen

Senior Staff Accountant

Similar Companies to OncoPep

AI Proteins

  • 11-50 11-50
  • 5 Million to 10 Million $ 5 Million to 10 Million

NextRNA Therapeutics

  • 11-50 11-50
  • Under 1 Million $ Under 1 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding OncoPep

Answer: OncoPep's headquarters are located at 520 Boston St, Boston, Massachusetts, 01845, United States

Answer: OncoPep's phone number is +19*********

Answer: OncoPep's official website is https://oncopep.com

Answer: OncoPep's revenue is Under $1 Million

Answer: OncoPep's SIC: 6771

Answer: OncoPep's NAICS: 523910

Answer: OncoPep has 11-50 employees

Answer: OncoPep is in Biotechnology

Answer: OncoPep top competitors include: AI Proteins , NextRNA Therapeutics

Answer: OncoPep contact info: Phone number: +19********* Website: https://oncopep.com

Answer: Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPeps T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access